Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Genetic variations in innate immunity genes affect response to Coxiella burnetii and are associated with susceptibility to chronic Q fever.

Jansen AFM, Schoffelen T, Bleeker-Rovers CP, Wever PC, Jaeger M, Oosting M, Adriaans A, Joosten LAB, Netea MG, van Deuren M, van de Vosse E.

Clin Microbiol Infect. 2019 May;25(5):631.e11-631.e15. doi: 10.1016/j.cmi.2018.08.011. Epub 2019 Jan 4.

PMID:
30616015
2.

Human IFN-γ immunity to mycobacteria is governed by both IL-12 and IL-23.

Martínez-Barricarte R, Markle JG, Ma CS, Deenick EK, Ramírez-Alejo N, Mele F, Latorre D, Mahdaviani SA, Aytekin C, Mansouri D, Bryant VL, Jabot-Hanin F, Deswarte C, Nieto-Patlán A, Surace L, Kerner G, Itan Y, Jovic S, Avery DT, Wong N, Rao G, Patin E, Okada S, Bigio B, Boisson B, Rapaport F, Seeleuthner Y, Schmidt M, Ikinciogullari A, Dogu F, Tanir G, Tabarsi P, Bloursaz MR, Joseph JK, Heer A, Kong XF, Migaud M, Lazarov T, Geissmann F, Fleckenstein B, Arlehamn CL, Sette A, Puel A, Emile JF, van de Vosse E, Quintana-Murci L, Di Santo JP, Abel L, Boisson-Dupuis S, Bustamante J, Tangye SG, Sallusto F, Casanova JL.

Sci Immunol. 2018 Dec 21;3(30). pii: eaau6759. doi: 10.1126/sciimmunol.aau6759.

3.

Susceptibility to mycobacterial disease due to mutations in IL-12Rβ1 in three Iranian patients.

Alinejad Dizaj M, Mortaz E, Mahdaviani SA, Mansouri D, Mehrian P, Verhard EM, Varahram M, Babaie D, Adcock IM, Garssen J, van de Vosse E, Velayati A.

Immunogenetics. 2018 Jun;70(6):373-379. doi: 10.1007/s00251-017-1041-3. Epub 2017 Dec 18.

4.

A 38-year-old woman with necrotising cervical lymphadenitis due to Histoplasma capsulatum.

van de Vosse E, van Wengen A, van der Meide WF, Visser LG, van Dissel JT.

Infection. 2017 Dec;45(6):917-920. doi: 10.1007/s15010-017-1060-x. Epub 2017 Aug 18.

5.

IFN-γR1 defects: Mutation update and description of the IFNGR1 variation database.

van de Vosse E, van Dissel JT.

Hum Mutat. 2017 Oct;38(10):1286-1296. doi: 10.1002/humu.23302. Epub 2017 Aug 3. Review.

PMID:
28744922
6.

Recurrent respiratory tract infections (RRTI) in the elderly: A late onset mild immunodeficiency?

van de Vosse E, van Ostaijen-Ten Dam MM, Vermaire R, Verhard EM, Waaijer JL, Bakker JA, Bernards ST, Eibel H, van Tol MJ, van Dissel JT, Haverkamp MH.

Clin Immunol. 2017 Jul;180:111-119. doi: 10.1016/j.clim.2017.05.008. Epub 2017 May 6.

7.

Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.

Suárez I, Lehmann C, Gruell H, Graeb J, Kochanek M, Fätkenheuer G, Plum G, van Wengen A, van de Vosse E, Hartmann P, Hanitsch LG, Rybniker J.

Clin Infect Dis. 2017 Aug 1;65(3):518-521. doi: 10.1093/cid/cix372.

PMID:
28430999
8.

Involvement of matrix metalloproteinases in chronic Q fever.

Jansen AFM, Schoffelen T, Textoris J, Mege JL, Bleeker-Rovers CP, Roest HIJ, Wever PC, Joosten LAB, Netea MG, van de Vosse E, van Deuren M.

Clin Microbiol Infect. 2017 Jul;23(7):487.e7-487.e13. doi: 10.1016/j.cmi.2017.01.022. Epub 2017 Feb 4.

9.

Intact interferon-γ response against Coxiella burnetii by peripheral blood mononuclear cells in chronic Q fever.

Schoffelen T, Textoris J, Bleeker-Rovers CP, Ben Amara A, van der Meer JW, Netea MG, Mege JL, van Deuren M, van de Vosse E.

Clin Microbiol Infect. 2017 Mar;23(3):209.e9-209.e15. doi: 10.1016/j.cmi.2016.11.008. Epub 2016 Nov 20.

10.

A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans.

Li Y, Oosting M, Smeekens SP, Jaeger M, Aguirre-Gamboa R, Le KTT, Deelen P, Ricaño-Ponce I, Schoffelen T, Jansen AFM, Swertz MA, Withoff S, van de Vosse E, van Deuren M, van de Veerdonk F, Zhernakova A, van der Meer JWM, Xavier RJ, Franke L, Joosten LAB, Wijmenga C, Kumar V, Netea MG.

Cell. 2016 Nov 3;167(4):1099-1110.e14. doi: 10.1016/j.cell.2016.10.017.

11.

Transduction of Herpesvirus saimiri-Transformed T Cells with Exogenous Genes of Interest.

Martínez-Barricarte R, de Jong SJ, Markle J, de Paus R, Boisson-Dupuis S, Bustamante J, van de Vosse E, Fleckenstein B, Casanova JL.

Curr Protoc Immunol. 2016 Nov 1;115:7.21C.1-7.21C.12. doi: 10.1002/cpim.15.

PMID:
27801513
12.

Single-Nucleotide Polymorphisms in the CALCA Gene Are Associated with Variation of Procalcitonin Concentration in Patients Undergoing Cardiac Surgery.

Schoe A, de Jonge E, Klautz RJ, van Dissel JT, van de Vosse E.

Am J Respir Crit Care Med. 2016 Sep 15;194(6):767-9. doi: 10.1164/rccm.201604-0772LE. No abstract available.

PMID:
27628079
13.

Deletion of the entire interferon-γ receptor 1 gene causing complete deficiency in three related patients.

de Vor IC, van der Meulen PM, Bekker V, Verhard EM, Breuning MH, Harnisch E, van Tol MJ, Wieringa JW, van de Vosse E, Bredius RG.

J Clin Immunol. 2016 Apr;36(3):195-203. doi: 10.1007/s10875-016-0244-y. Epub 2016 Mar 1.

14.

Erratum to: Intact IFN-γR1 Expression and Function Distinguishes Langerhans Cell Histiocytosis From Mendelian Susceptibility to Mycobacterial Disease.

Quispel WT, Stegehuis-Kamp JA, Santos SJ, van Wengen A, Dompeling E, Egeler RM, van de Vosse E, van Halteren AG.

J Clin Immunol. 2016 Feb;36(2):171-2. doi: 10.1007/s10875-016-0235-z. No abstract available.

PMID:
26783113
15.

Genetic variation in TLR10 is not associated with chronic Q fever, despite the inhibitory effect of TLR10 on Coxiella burnetii-induced cytokines in vitro.

Ammerdorffer A, Stappers MH, Oosting M, Schoffelen T, Hagenaars JC, Bleeker-Rovers CP, Wegdam-Blans MC, Wever PC, Roest HJ, van de Vosse E, Netea MG, Sprong T, Joosten LA.

Cytokine. 2016 Jan;77:196-202. doi: 10.1016/j.cyto.2015.09.005. Epub 2015 Sep 11.

PMID:
26364993
16.

Urinary proteins, vitamin D and genetic polymorphisms as risk factors for febrile urinary tract infection and relation with bacteremia: a case control study.

van der Starre WE, van Nieuwkoop C, Thomson U, Zijderveld-Voshart MS, Koopman JP, van der Reijden TJ, van Dissel JT, van de Vosse E.

PLoS One. 2015 Mar 25;10(3):e0121302. doi: 10.1371/journal.pone.0121302. eCollection 2015.

17.

Genetic Variation in Pattern Recognition Receptors and Adaptor Proteins Associated With Development of Chronic Q Fever.

Schoffelen T, Ammerdorffer A, Hagenaars JC, Bleeker-Rovers CP, Wegdam-Blans MC, Wever PC, Joosten LA, van der Meer JW, Sprong T, Netea MG, van Deuren M, van de Vosse E.

J Infect Dis. 2015 Sep 1;212(5):818-29. doi: 10.1093/infdis/jiv113. Epub 2015 Feb 26.

PMID:
25722298
18.

The C-type lectin receptor CLECSF8/CLEC4D is a key component of anti-mycobacterial immunity.

Wilson GJ, Marakalala MJ, Hoving JC, van Laarhoven A, Drummond RA, Kerscher B, Keeton R, van de Vosse E, Ottenhoff TH, Plantinga TS, Alisjahbana B, Govender D, Besra GS, Netea MG, Reid DM, Willment JA, Jacobs M, Yamasaki S, van Crevel R, Brown GD.

Cell Host Microbe. 2015 Feb 11;17(2):252-9. doi: 10.1016/j.chom.2015.01.004.

19.

The Hd, Hj, and Hz66 flagella variants of Salmonella enterica serovar Typhi modify host responses and cellular interactions.

Schreiber F, Kay S, Frankel G, Clare S, Goulding D, van de Vosse E, van Dissel JT, Strugnell R, Thwaites G, Kingsley RA, Dougan G, Baker S.

Sci Rep. 2015 Jan 22;5:7947. doi: 10.1038/srep07947.

20.

Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation.

Vogelaar IP, van der Post RS, van de Vosse E, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ, Gómez García E.

Fam Cancer. 2015 Mar;14(1):89-94. doi: 10.1007/s10689-014-9764-x.

PMID:
25467645
21.

Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer.

Buffen K, Oosting M, Quintin J, Ng A, Kleinnijenhuis J, Kumar V, van de Vosse E, Wijmenga C, van Crevel R, Oosterwijk E, Grotenhuis AJ, Vermeulen SH, Kiemeney LA, van de Veerdonk FL, Chamilos G, Xavier RJ, van der Meer JW, Netea MG, Joosten LA.

PLoS Pathog. 2014 Oct 30;10(10):e1004485. doi: 10.1371/journal.ppat.1004485. eCollection 2014 Oct.

22.

Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS).

Haverkamp MH, van de Vosse E, Goldbach-Mansky R, Holland SM.

Clin Exp Immunol. 2014 Sep;177(3):720-31. doi: 10.1111/cei.12361.

23.

PTX3 deficiency and aspergillosis.

de Boer MG, Halkes CJ, van de Vosse E.

N Engl J Med. 2014 Apr 24;370(17):1665-6. doi: 10.1056/NEJMc1402787. No abstract available.

PMID:
24758633
24.

Role of genetic variants of autophagy genes in susceptibility for non-medullary thyroid cancer and patients outcome.

Plantinga TS, van de Vosse E, Huijbers A, Netea MG, Joosten LA, Smit JW, Netea-Maier RT.

PLoS One. 2014 Apr 16;9(4):e94086. doi: 10.1371/journal.pone.0094086. eCollection 2014.

25.

Correlating interleukin-12 stimulated interferon-γ production and the absence of ectodermal dysplasia and anhidrosis (EDA) in patients with mutations in NF-κB essential modulator (NEMO).

Haverkamp MH, Marciano BE, Frucht DM, Jain A, van de Vosse E, Holland SM.

J Clin Immunol. 2014 May;34(4):436-43. doi: 10.1007/s10875-014-9998-2. Epub 2014 Feb 28.

PMID:
24682681
26.

Intact IFN-γR1 expression and function distinguishes Langerhans cell histiocytosis from mendelian susceptibility to mycobacterial disease.

Quispel WT, Stegehuis-Kamp JA, Santos SJ, van Wengen A, Dompeling E, Egeler RM, van de Vosse E, van Halteren AG.

J Clin Immunol. 2014 Jan;34(1):84-93. doi: 10.1007/s10875-013-9959-1. Epub 2013 Nov 20. Review. Erratum in: J Clin Immunol. 2014 Jul;34(5):600. J Clin Immunol. 2016 Feb;36(2):171-2.

PMID:
24254535
27.

Autophagy is redundant for the host defense against systemic Candida albicans infections.

Smeekens SP, Malireddi RK, Plantinga TS, Buffen K, Oosting M, Joosten LA, Kullberg BJ, Perfect JR, Scott WK, van de Veerdonk FL, Xavier RJ, van de Vosse E, Kanneganti TD, Johnson MD, Netea MG.

Eur J Clin Microbiol Infect Dis. 2014 May;33(5):711-22. doi: 10.1007/s10096-013-2002-x. Epub 2013 Nov 8.

PMID:
24202731
28.

Nontuberculous mycobacterial infections in children with inborn errors of the immune system.

Haverkamp MH, van de Vosse E, van Dissel JT.

J Infect. 2014 Jan;68 Suppl 1:S134-50. doi: 10.1016/j.jinf.2013.09.024. Epub 2013 Oct 8. Review.

PMID:
24119826
29.

Differential expression and function of human IL-12Rβ2 polymorphic variants.

de Paus RA, Geilenkirchen MA, van Riet S, van Dissel JT, van de Vosse E.

Mol Immunol. 2013 Dec;56(4):380-9. doi: 10.1016/j.molimm.2013.07.002. Epub 2013 Aug 1.

PMID:
23911393
30.

IL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation database.

van de Vosse E, Haverkamp MH, Ramirez-Alejo N, Martinez-Gallo M, Blancas-Galicia L, Metin A, Garty BZ, Sun-Tan Ç, Broides A, de Paus RA, Keskin Ö, Çağdaş D, Tezcan I, Lopez-Ruzafa E, Aróstegui JI, Levy J, Espinosa-Rosales FJ, Sanal Ö, Santos-Argumedo L, Casanova JL, Boisson-Dupuis S, van Dissel JT, Bustamante J.

Hum Mutat. 2013 Oct;34(10):1329-39. doi: 10.1002/humu.22380. Epub 2013 Aug 8. Review.

31.

The influence of influenza virus infections on the development of tuberculosis.

de Paus RA, van Crevel R, van Beek R, Sahiratmadja E, Alisjahbana B, Marzuki S, Rimmelzwaan GF, van Dissel JT, Ottenhoff TH, van de Vosse E.

Tuberculosis (Edinb). 2013 May;93(3):338-42. doi: 10.1016/j.tube.2013.02.006. Epub 2013 Mar 7.

32.

The R156H variation in IL-12Rβ1 is not a mutation.

van de Vosse E, van Dissel JT, Palamaro L, Giardino G, Santamaria F, Romano R, Fusco A, Montella S, Salerno M, Ursini MV, Pignata C.

Ital J Pediatr. 2013 Feb 14;39:12. doi: 10.1186/1824-7288-39-12.

33.

Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β.

de Paus RA, van Wengen A, Schmidt I, Visser M, Verdegaal EM, van Dissel JT, van de Vosse E.

Cytokine. 2013 Feb;61(2):645-55. doi: 10.1016/j.cyto.2012.12.005. Epub 2013 Jan 5.

PMID:
23299081
34.

Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis.

Ottenhoff TH, Dass RH, Yang N, Zhang MM, Wong HE, Sahiratmadja E, Khor CC, Alisjahbana B, van Crevel R, Marzuki S, Seielstad M, van de Vosse E, Hibberd ML.

PLoS One. 2012;7(9):e45839. doi: 10.1371/journal.pone.0045839. Epub 2012 Sep 21.

35.

Cutaneous leukocytoclastic vasculitis due to Salmonella enteritidis in a child with interleukin-12 receptor beta-1 deficiency.

Filiz S, Kocacik Uygun DF, Verhard EM, van Dissel JT, Uygun V, Bassorgun C, Bingol A, Yegin O, van de Vosse E.

Pediatr Dermatol. 2014 Mar-Apr;31(2):236-40. doi: 10.1111/j.1525-1470.2012.01856.x. Epub 2012 Sep 25.

PMID:
23004925
36.

Severe disseminated mycobacterial infection in a boy with a novel mutation leading to IFN-γR2 deficiency.

Kilic SS, van Wengen A, de Paus RA, Celebi S, Meziane B, Hafizoglu D, van Dissel JT, van de Vosse E.

J Infect. 2012 Dec;65(6):568-72. doi: 10.1016/j.jinf.2012.08.008. Epub 2012 Aug 15.

PMID:
22902943
37.

Polymorphisms in autophagy genes and susceptibility to tuberculosis.

Songane M, Kleinnijenhuis J, Alisjahbana B, Sahiratmadja E, Parwati I, Oosting M, Plantinga TS, Joosten LA, Netea MG, Ottenhoff TH, van de Vosse E, van Crevel R.

PLoS One. 2012;7(8):e41618. doi: 10.1371/journal.pone.0041618. Epub 2012 Aug 6.

38.

Disseminated Mycobacterium genavense infection in a patient with a novel partial interleukin-12/23 receptor β1 deficiency.

Potjewijd J, de Paus RA, van Wengen A, Damoiseaux J, Verbon A, van de Vosse E.

Clin Immunol. 2012 Aug;144(2):83-6. doi: 10.1016/j.clim.2012.05.007. Epub 2012 May 24.

PMID:
22695533
39.

Polymorphisms in SP110 are not associated with pulmonary tuberculosis in Indonesians.

Png E, Alisjahbana B, Sahiratmadja E, Marzuki S, Nelwan R, Adnan I, van de Vosse E, Hibberd M, van Crevel R, Ottenhoff TH, Seielstad M.

Infect Genet Evol. 2012 Aug;12(6):1319-23. doi: 10.1016/j.meegid.2012.04.006. Epub 2012 Apr 12.

PMID:
22522001
40.

Pulmonary Mycobacterium abscessus: a canary in the cystic fibrosis coalmine.

Haverkamp MH, van Wengen A, de Visser AW, van Kralingen KW, van Dissel JT, van de Vosse E.

J Infect. 2012 Jun;64(6):609-12. doi: 10.1016/j.jinf.2012.02.010. Epub 2012 Feb 23.

PMID:
22366207
41.

Common variants at 11p13 are associated with susceptibility to tuberculosis.

Thye T, Owusu-Dabo E, Vannberg FO, van Crevel R, Curtis J, Sahiratmadja E, Balabanova Y, Ehmen C, Muntau B, Ruge G, Sievertsen J, Gyapong J, Nikolayevskyy V, Hill PC, Sirugo G, Drobniewski F, van de Vosse E, Newport M, Alisjahbana B, Nejentsev S, Ottenhoff TH, Hill AV, Horstmann RD, Meyer CG.

Nat Genet. 2012 Feb 5;44(3):257-9. doi: 10.1038/ng.1080.

42.

Toll-like receptor 1 polymorphisms increase susceptibility to candidemia.

Plantinga TS, Johnson MD, Scott WK, van de Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Kremer D, Laird GM, Oosting M, Joosten LA, van der Meer JW, van Dissel JT, Walsh TJ, Perfect JR, Kullberg BJ, Netea MG.

J Infect Dis. 2012 Mar 15;205(6):934-43. doi: 10.1093/infdis/jir867. Epub 2012 Feb 1.

43.

A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians.

Png E, Alisjahbana B, Sahiratmadja E, Marzuki S, Nelwan R, Balabanova Y, Nikolayevskyy V, Drobniewski F, Nejentsev S, Adnan I, van de Vosse E, Hibberd ML, van Crevel R, Ottenhoff TH, Seielstad M.

BMC Med Genet. 2012 Jan 13;13:5. doi: 10.1186/1471-2350-13-5.

44.

A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activation.

Mul D, Wu S, de Paus RA, Oostdijk W, Lankester AC, Duyvenvoorde HA, Ruivenkamp CA, Losekoot M, Tol MJ, De Luca F, van de Vosse E, Wit JM.

Eur J Endocrinol. 2012 Apr;166(4):743-52. doi: 10.1530/EJE-11-0774. Epub 2012 Jan 3.

PMID:
22214923
45.

Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study.

Johnson MD, Plantinga TS, van de Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Kremer D, Laird GM, Oosting M, Joosten LA, van der Meer JW, van Dissel JT, Walsh TJ, Perfect JR, Kullberg BJ, Scott WK, Netea MG.

Clin Infect Dis. 2012 Feb 15;54(4):502-10. doi: 10.1093/cid/cir827. Epub 2011 Dec 5.

46.

"Mycobacterium tilburgii" infection in two immunocompromised children: importance of molecular tools in culture-negative mycobacterial disease diagnosis.

Hartwig NG, Warris A, van de Vosse E, van der Zanden AG, Schülin-Casonato T, van Ingen J, van Hest R.

J Clin Microbiol. 2011 Dec;49(12):4409-11. doi: 10.1128/JCM.05460-11. Epub 2011 Oct 19.

47.

Natural antibodies against bone morphogenic proteins and interferons in healthy donors and in patients with infections linked to type-1 cytokine responses.

Sauerborn M, van de Vosse E, Delawi D, van Dissel JT, Brinks V, Schellekens H.

J Interferon Cytokine Res. 2011 Sep;31(9):661-9. doi: 10.1089/jir.2010.0075. Epub 2011 May 25.

PMID:
21612442
48.

Influence of polymorphisms in innate immunity genes on susceptibility to invasive aspergillosis after stem cell transplantation.

de Boer MG, Jolink H, Halkes CJ, van der Heiden PL, Kremer D, Falkenburg JH, van de Vosse E, van Dissel JT.

PLoS One. 2011 Apr 4;6(4):e18403. doi: 10.1371/journal.pone.0018403.

49.

Effect of amino acid substitutions in the human IFN-γR2 on IFN-γ responsiveness.

de Paus RA, Kilic SS, van Dissel JT, van de Vosse E.

Genes Immun. 2011 Mar;12(2):136-44. doi: 10.1038/gene.2010.74. Epub 2011 Jan 20.

PMID:
21248774
50.

IFN-α cannot substitute lack of IFN-γ responsiveness in cells of an IFN-γR1 deficient patient.

van de Wetering D, van Wengen A, Savage ND, van de Vosse E, van Dissel JT.

Clin Immunol. 2011 Mar;138(3):282-90. doi: 10.1016/j.clim.2010.12.005. Epub 2011 Jan 8.

Supplemental Content

Loading ...
Support Center